Tirzepatide, a innovative medication, is generating significant excitement in the medical community as a viable treatment for both diabetes, type 2 and reducing body fat. This dual-action drug works by targeting two distinct receptors, GLP-1 and GIP, leading to enhanced glycemic management and no